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Cardiac hybrid imaging: state-of-the-art
Abstract
The field of noninvasive cardiac imaging has experienced enormous advances including computerized
tomography coronary angiography (CTCA). Invasive angiography remains the anatomic standard of
reference but it is associated with a non-negligible peri-procedural morbidity and mortality which
suggests confining its use to patients who will benefit from a revascularization procedure. Many factors
that are beyond the simple quantification of diameter narrowing and therefore cannot be fully assessed
with luminology will eventually determine whether or not a given lesion produces stress-induced
ischemia. Myocardial perfusion scintigraphy by single photon emission computerized tomography
(SPECT) is one of the most widely used and well established noninvasive tools for the diagnosis of
ischemic heart disease. Although positron emission tomography (PET) offers a higher accuracy than
SPECT its use is often limited to large centers. This article explains the great potential of cardiac hybrid
imaging which allows a comprehensive evaluation of coronary artery disease as it combines both
morphological and functional information by fusing either SPECT or PET with CTCA. SPECT/CT and
PET/CT hybrid imaging can provide entirely noninvasively unique information which helps improving
diagnostic assessment and risk stratification and also impacts decision making with regard to
revascularization in patients with coronary artery disease.
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Abstract: The field of noninvasive cardiac imaging has experienced enormous advances including CT 
coronary angiography. Invasive angiography remains the anatomic standard of reference but it is 
associated with a non-negligible peri-procedural morbidity and mortality which suggests confining its 
use to patients who will benefit from a revascularization procedure. Many factors that are beyond the 
simple quantification of diameter narrowing and therefore cannot be fully assessed with luminology 
will eventually determine whether or not a given lesion produces stress-induced ischemia. Myocardial 
perfusion scintigraphy by SPECT is one of the most widely used and well established noninvasive tools 
for the diagnosis of ischemic heart disease. Although PET offers a higher accuracy than SPECT its use is 
often limited to large centers. This article explains the great potential of cardiac hybrid imaging which 
allows a comprehensive evaluation of coronary artery disease as it combines both morphological and 
functional information by fusing either SPECT or PET with CT coronary angiography. SPECT/CT and 
PET/CT hybrid imaging can provide entirely noninvasively unique information which helps improving 
diagnostic assessment and risk stratification and also impacts decision making with regard to 
revascularization in Patients with coronary artery disease.
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Abstract
The field of noninvasive cardiac imaging has experienced enormous advances
including CT coronary angiography. Invasive angiography remains the anatomic 
standard of reference but it is associated with a non-negligible peri-procedural 
morbidity and mortality which suggests confining its use to patients who will benefit 
from a revascularization procedure. Many factors that are beyond the simple 
quantification of diameter narrowing and therefore cannot be fully assessed with 
luminology will eventually determine whether or not a given lesion produces stress-
induced ischemia. Myocardial perfusion scintigraphy by SPECT is one of the most 
widely used and well established noninvasive tools for the diagnosis of ischemic 
heart disease. Although PET offers a higher accuracy than SPECT its use is often
limited to large centers. This article explains the great potential of cardiac hybrid 
imaging which allows a comprehensive evaluation of coronary artery disease as it 
combines both morphological and functional information by fusing either SPECT or 
PET with CT coronary angiography. SPECT/CT and PET/CT hybrid imaging can 
provide entirely noninvasively unique information which helps improving diagnostic 
assessment and risk stratification and also impacts decision making with regard to 
revascularization in Patients with coronary artery disease.
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2Coronary stenoses and ischemic heart disease: two faces of the same coin
Despite the trend in modern medicine away from intervention towards prevention the 
treatment of coronary artery disease has remained of great importance in 
industrialized countries. Although invasive coronary angiography is affected by a 
considerable morbidity (1.5%) (1) and mortality (0.3%) (2) this has remained the most 
established method for visualization of the coronary arteries and, thus, the standard 
of reference for the diagnosis of coronary stenoses. It is, however, far from being a 
perfect diagnostic tool as in fact its accuracy is severely hampered by a large 
intraobserver and interobserver variability in defining the anatomic relevance of 
stenoses (up to 50%) (3,4). This is further underlined by the fact that invasive 
coronary angiography is very poorly correlated with postmortem coronary anatomy
(5,6). Most importantly, angiographic findings are poor predictors of physiologic 
relevance of a coronary stenosis (4,7-10). A substantial fraction – namely between 
20% and 40% - of all diagnostic invasive coronary angiograms reveal clinically 
insignificant disease (1). This has lead to a search for strategies for non-invasive 
coronary imaging, among them dichromatic synchrotron radiation (11), electron beam 
tomography (12), magnetic resonance imaging (13,14), and multidetector 
computerized tomography coronary angiography (CTCA) (15). Only the latter has 
recently emerged as an acceptable alternative to the invasive coronary angiography 
for visualization of the coronary anatomy.
It is very likely, but still awaits confirmation in large multicenter trials, that CTCA will 
help to change the fact that at present only about a third of patients referred to 
catheterization will eventually undergo a revascularization procedure (16) leaving 
most of the patients exposed to the risks but without the benefit of a catheter in their 
coronary arteries. Coronary anatomy, however, may not allow to estimate with 
certainty the pathophysiologic relevance of a coronary lesion, as particularly in 
intermediate lesions there are many factors influencing the interrelation between 
anatomic finding and hemodynamic consequences which can not be fully elucidated 
by anatomic evaluation alone, not even with the use of quantitative coronary 
angiograpy (17). Therefore, according to the actual European and American 
guidelines a test for ischemia before any elective coronary angiography is mandatory 
(18-20). It appears, however, that there is still a large gap between these evidence-
based guidelines and the daily clinical routine, as underlined by a recent study by Lin 
et al. reporting that in a large cohort of patients (n = 23887) referred for elective 
3coronary intervention only a minority (44%) had undergone any kind of stress testing 
in a 90-day period prior to the intervention (21). This impressively underlines the 
need to increase both the awareness of the importance and the availability of non-
invasive testing for coronary artery disease.
Role of single photon emission computerized tomography (SPECT)
Nuclear myocardial perfusion imaging (MPI) with SPECT represents the most widely 
available, robust and by far best established non-invasive method for this purpose 
(22), while coronary angiography has remained the standard of reference for the 
anatomy of the epicardial coronary artery anatomy. A perfect agreement of MPI 
SPECT and coronary angiography cannot be expected and is not a main prerequisite
for its clinical value. In the non-invasive diagnostic algorithm the main role of SPECT 
is not to correctly predict or exclude epicardial coronary lesions but rather to evaluate 
the physiological relevance of known or suspected coronary stenoses. Nevertheless, 
as invasive coronary angiography is the generally accepted standard of reference for 
coronary lesions the findings of functional tests including SPECT have often been 
compared to those of coronary angiography. The results may depend at least in part 
from the size and selection of the study population. One of the largest recent reports, 
the British ROBUST-study, included 2560 patients who were randomized to one of 
the commonly used tracers (Thallium, Sestamibi or Tetrofosmin) applying mainly 
adenosine stress. The authors found a sensitivity of 91% and a specificity of 87% 
without differences between the tracers (23).
Role of positron emission tomography (PET)
The most important perfusion tracers for clinical PET are N-13-ammonia and –
mainly in the US – Rubidium-82. Several studies involving over 1400 patients have 
recently been included in a meta-analysis which confirmed the high sensitivity and 
specificity of PET myocardial perfusion imaging. The use of Rubidium-82 offers the 
advantage that there is no need of any cyclotron. By contrast, the application of N-
13-ammonia and alternatively of O-15-water requires an on-site cyclotron due to the 
short half lives (i.e. 10 minutes and 2 minutes, respectively). This major drawback 
seems to be responsible for the fact that this technique has not gained wide 
acceptance in the clinical arena. Theoretically, O-15-water may appear to be the 
ideal myocardial perfusion tracer as it diffuses almost freely through cell membranes.
4Unfortunately it does not allow achieving a strong signal-to-noise ratio between the 
myocardium and the ventricular blood pool due to the lack of accumulation into the 
myocytes which precludes obtaining clinically meaningful perfusion images.
Therefore, application of O-15-water can only provide useful information if 
postprocessing with quantitative evaluation is performed. As this is a relative complex 
procedure O-15-water has mainly remained confined to scientific applications (24).
As long as an on-site cyclotron is available N-13-ammonia has remained the 
perfusion tracer of choice because it provides high-quality perfusion images for visual 
analysis for daily clinical routine and at the same time also allows quantification of 
global and regional myocardial perfusion. Because PET confers a higher resolution 
than SPECT and inherently uses attenuation correction there is a general expert 
consensus that sensitivity and specificity of PET is superior to that of SPECT 
although this perception is not based on a large number of patients studied in head-
to-head comparisons between SPECT and PET. Finally, it remains to be elucidated 
whether the higher costs of PET will be justified by the improvement of accuracy 
compared to SPECT.
Definition and general aspects of hybrid imaging
The consideration of the duality of morphology and function has gained importance 
over the last few years. This has lead to the conviction that comprehensive 
assessment of coronary disease should include both, information on coronary lesion 
morphology and on myocardial perfusion. Non-invasive assessment of myocardial 
perfusion scintigraphy has been available for more than three decades. By contrast 
non-invasive coronary angiography has only been introduced recently into the clinical 
arena after the advent of multi-detector computed tomography (15). The latter 
technology has finally met the requirements with regard to temporal and spatial 
resolution to allow clinical use. This has provided the base for combination of CTCA 
with complementary nuclear modalities into hybrid imaging. In addition to the 
developments in non-invasive CTCA advances in image processing software (Figure
1, a and b) (25) and the introduction of hybrid scanners have paved the way for 
integrating image data sets from different modalities into hybrid images. Such 
software reliably allows superposition of myocardial segments depicted by SPECT or 
PET onto cardiac CT anatomy, resulting in an easily interpretable panoramic view of 
the heart, which integrates the high-resolution 3-dimensional information of the 
5coronary arteries with the functional information of the SPECT perfusion image
(Figure 1, c and d). Despite the integration of high-end CT devices with the 
capability to perform state-of-the-art coronary CT angiography into nuclear scanners 
to form dedicated cardiac hybrid scanners, manual image coregistration may remain 
indispensable. Studies with X-ray based attenuation correction have reported that 
automated coregistration of CT and SPECT images is often unreliable and manual 
correction for misalignment is needed in the vast majority of the cases (26,27). 
Dedicated cardiac fusion software packages are now commercially available allowing 
software-based hybrid imaging with an excellent interobserver reproducibility and 
short processing durations (25).
Although fusion of invasive coronary angiography with SPECT has been attempted in 
the past, the warping and 3-dimensional unification by forcing a planar 2-dimensional 
angiogram into a fusion with a 3-dimensional perfusion scan data set provided 
technically unsatisfying results. In addition, such approach precludes non-invasive 
preplanning of the intervention as the information on the coronary anatomy is 
obtained by invasive coronary angiography. During such procedure, however, rapid 
decision making should not be delayed by the need of time consuming offline 
analyses. This drawback may explain why this concept which does not allow careful 
non-invasive planning of the elective intervention has not been adopted into daily 
clinical routine.
At this point it should be clarified that the definition of hybrid imaging is the 
combination and fusing of two imaging data stets by which both modalities equally 
contribute to image information (28). This is important as the term hybrid imaging has 
also been used in different contexts potentially raising some confusion about its exact 
meaning. For example, some authors have used the term hybrid imaging for X-ray 
based attenuation correction although in such setting the CT images do not provide 
neither anatomical nor functional information but rather exclusively contribute to 
improve image quality of the other modality (PET or SPECT). In fact, the parametric 
maps obtained from low-dose CT do not provide image information beyond that 
needed for attenuation correction (26,29). This is underlined by the fact that Ge-68
sources used in the previous generation of PET scanners provided the same 
information, but such type of imaging was not perceived as hybrid imaging as 
attenuation correction does not contribute to topographic image information. Others 
have used the term “hybrid imaging” for the side-by-side analysis of MPI and CT 
6images (30). To avoid confusion we suggest using the term hybrid imaging for any 
combination of structural and functional information beyond that offered by 
attenuation correction or side-by-side analysis, i.e. fusion of two separate data sets 
into one image (Figure 1d). Thus, this definition would not include attenuation 
corrected images without integrating anatomical information. Similarly, separate 
acquisition of structural information as well as functional (for example perfusion) data 
on two separate scanners or on one hybrid device would allow mental integration of 
side-by-side evaluation but only fusion of both pieces of information would result in a 
hybrid image.
Role of hybrid imaging: Implications and limitations
The continuing rapid evolution of CTCA suggests that, when combined with perfusion 
imaging, it has the potential to be implemented into clinical practice. As mentioned 
above the advancements in fast-processing software for 3-dimensional 
reconstructions have allowed initial promising attempts of purely noninvasive CAD 
assessment directly relating individual myocardial wall territories with impaired 
myocardial perfusion to the subtending coronary artery by use of PET and CT (31).
Recent data using SPECT and CT suggest that hybrid imaging provides added 
diagnostic clinical value beyond that of either technique alone or that of side-by-side 
analysis (28,32,33). The added value seems to be found on both sides of the 
diagnostic spectrum, i.e. in low risk populations (34) as well as in those with multi-
vessel disease (33). In low risk populations hybrid imaging may increase the 
confidence to rule out coronary artery disease for example in the stepwise evaluation 
of coronary artery disease when the first study has yielded equivocal results and a 
second modality is needed to finally rule out with certainty any disease. Many of 
those patients would end up with invasive coronary angiography while hybrid imaging 
increases diagnostic confidence by avoiding equivocal findings which helps to reduce 
the number of patients unnecessarily exposed to the non-negligible risks of morbidity 
and mortality (2) associated with invasive coronary procedures. A the other end of 
the spectrum, i.e. in patients who are older then those mentioned above and who 
often suffer from multivessel disease with more jeopardized myocardium, hybrid 
imaging provides important comprehensive information to allow for timely and 
appropriate treatment. In such setting the value of hybrid imaging lies far beyond the 
simple addition of a further diagnostic test as it allows accurate spatial association of 
7perfusion defects to their subtending coronary stenosis (Figure 2; (35)). Hybrid 
imaging is a completely non-invasive approach to coronary artery disease which 
allows obtaining important information prior to any invasive procedure and provides 
the detailed information for evidence driven intervention targeting relevant lesion 
only. Although the CT part of hybrid imaging has excellent abilities in ruling out 
hemodynamic relevant coronary artery disease, an abnormal CTCA – like an 
abnormal conventional angiography study - is a poor predictor of ischemia, and 
further perfusion imaging testing is warranted to identify those patients who might 
benefit from a revascularization procedure (36,37) and those in whom conservative 
management and risk modification may be justified (38). Conversely, a normal 
myocardial perfusion imaging result does not exclude the presence of subclinical 
coronary disease as assessable with CTCA and conventional coronary angiography 
for which aggressive cardiovascular risk modification may be warranted. The 
incongruence of CTCA and myocardial perfusion imaging is inherent to the duality of 
morphologic versus functional testing. The technologic refinements implemented in 
the latest CT scanner generations have reduced the number of nonevaluable 
coronary segments and further improvements may be expected. However, no matter 
how accurate CTCA will possibly get with future advances in technology, the two 
pieces of information obtained with perfusion imaging versus morphology are difficult 
to compare. This has been recently documented by Gaemperli et al. who found that 
the receiver operator characteristic analysis for detection of perfusion defects (by 
SPECT) showed similar area under the curves for the reference standard, 
conventional angiography, and for CT angiography, documenting comparable 
performance and limitations of both anatomic morphologic techniques (39). Hence, 
many factors that are beyond the simple quantification of diameter narrowing and that 
therefore cannot be fully assessed with luminology will eventually determine whether 
or not a given lesion produces stress-induced ischemia.
First clinical results from our institution appear encouraging, and support that hybrid 
images offer superior diagnostic information with regard to identification of the culprit 
vessel with the hemodynamic relevant lesion and increases diagnostic confidence for 
categorizing intermediate lesions and equivocal perfusion defects as in almost one 
third of patients the fused analysis provided added diagnostic information not 
obtained on side-by-side analysis (33). The incremental value seems most 
pronounced for functionally relevant lesions in distal segments and diagonal 
8branches and in vessels with extensive coronary lesions or heavy calcifications on 
CTCA. Other groups have confirmed the added value of hybrid cardiac imaging (40). 
Results from a first multicenter study underline the value of a combined functional 
and anatomical approach even without hybrid imaging showing that this combination 
allows improved risk stratification (41). The clinical usefulness in terms of impact on 
treatment strategy and subsequently on outcome by hybrid imaging remains, 
however, to be determined in prospective and long-term studies. Similarly, it remains 
uncertain at this point whether hybrid scanners offer advantages over software fusion 
of data sets obtained from different scanners, as by either way one can obtain hybrid 
images (28). The scan time discrepancy between emission from nuclear and CT 
transmission determines that high-end CT facilities constituting the CT component of 
hybrid cardiac scanners will be blocked by long emission scan time and is therefore 
forced to operate at low capacity. On the other hand, a combined device may fit into 
one room and needs one operating team and does not require positioning of the 
patient into two different scanners. The development of ultrafast SPECT scanners 
allowing substantially shorter acquisition time may shift the balance towards hybrid 
scanners in the future.
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Figure 1
Illustration of the main software fusion process including a) image coregistration, b) 
epicardial contour detection, c) coronary artery segmentation, and d) 3-dimensional 
volume rendered fusion.
Figure 2
a) Polar maps of myocardial perfusion imaging with 99mTc-Tetrofosmin show a 
pronounced inferior basal perfusion defect at adenosine stress (upper panel) which is 
almost entirely reversible at rest (lower panel) indicating an ischemia. The territory of 
this ischemia would generally be assumed to be subtended by the right coronary 
artery (RCA).
b) Anterior view of the 3-dimensional hybrid cardiac image obtained by fusion the 
polar maps with the volume rendered CT-coronary angiography of the same patient. 
Despite calcifications in the left anterior descending artery there are no perfusion 
defects in the anterior wall.
c) The posterior view allows recognizing, that in this patient the ischemic basal 
inferior territory is subtended by the circumflex artery (CX) causing the ischemia due 
to a tight lesion. By contrast, the RCA does not contribute to this ischemia. (Modified 
with permission from (35), copyright University Hospital Zurich, Switzerland)
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